Valerian Root

Valerian root (Valeriana officinalis) is theorized to alleviate canine stress and modify reactive behaviors primarily by enhancing GABAergic signaling within the central nervous system. The active constituents, such as valerenic acid, are posited to act as mild sedatives by inhibiting the enzyme GABA-transaminase, which is responsible for the breakdown of the inhibitory neurotransmitter GABA. By potentially increasing the synaptic concentration of GABA, valerian root is hypothesized to dampen neuronal excitability and reduce the physiological "noise" associated with fear or hyper-arousal. Additionally, it is suggested that valerian may interact with adenosine receptors to promote a state of relaxation, effectively lowering the dog’s reactive threshold to environmental stressors like thunderstorms or travel without causing the profound sedation seen in clinical anesthetics.

Despite these proposed mechanisms, clinical evidence in dogs remains limited and inconsistent. In randomized observational studies evaluating valerian-based aromatic blends, no significant differences in behavior were identified between the treatment and placebo groups, suggesting that these formulations may not consistently reduce behavioral indicators of stress (Taylor & Madden, 2016). However, recent neurochemical analyses have provided preliminary evidence that oral valerian extract may influence central biomarkers, specifically by decreasing plasma dopamine levels, a shift that could potentially correlate with a reduction in hyper-arousal (Cagin et al., 2025). While these neurophysiological markers are promising, further controlled, placebo-based studies are necessary to establish the clinical relevance of valerian root as a standalone treatment for canine anxiety.